মোঃ সফি উদ্দীন এর সকল পোস্ট

Sheikh Mujib

You are resting in peace in Tungipara
Kissing the holy soil of the Bengal,
You are the best of a thousand years.
I bow down to you again and again-
Sheikh Mujib, Sheikh Mujib.

On March 7th, your glorious speech
Brought a titanic flood of revival
In everyone’s heart in the Bengal,
You bestowed cheers as ‘Bangabandhu’-
Sheikh Mujib, Sheikh Mujib.

Traitor’s bullet inflicted a cruel blow,
Your holy blood flowed like a falls
On the stairs of the house thirty-two.
Yet you are in sixteen million lives-
Sheikh Mujib, Sheikh Mujib.

As long as Madhumati will remain
Flowing in the heart of the Bengal,
Until then, you will be in poetry.
You will light up forever in the sky-
Sheikh Mujib, Sheikh Mujib.

মাটির ঘরে ঘুমাবিরে মাটির চাদরে

মাটির দেহ মাটিতেই যাবে মিশে
ভবের লীলা সাঙ্গ হলে শেষে,
তবে কেন করিস এতো বড়াই
মরণ হলে জায়গা হবে একটাই।
মাটির ঘরে ঘুমাবিরে মাটির চাদরে
জাগবিনা আর সবিতার পরম আদরে।

খাঁচা ছেড়ে পাখি একদিন যাবে উড়ে
ফিরে আর আসিবেনা সে কোনদিন ওরে,
দুইদিনের এই দুনিয়া – কেন ভুলে যাসরে
এপার ছেড়ে যেতে হবে এ জীবন সংহারে।
মাটির ঘরে ঘুমাবিরে মাটির চাদরে
জাগবিনা আর সবিতার পরম আদরে।

আলো আর অন্ধকারে কাটে জীবন
বয়সের ভারে ক্লান্ত হয় মন ও মনন,
কামনা বাসনায় চিরকাল যাবেনারে
রবের ডাকে একদিন চলে যাবিরে।
মাটির ঘরে ঘুমাবিরে মাটির চাদরে
জাগবিনা আর সবিতার পরম আদরে।

No More Love

All the love in this city
Have died of virus,
You won’t find it
In the heart of Linus.

No more love
In the fragrance of roses,
No more love
In the glorious glory of Moses.

No more love
In the water of the Jamuna,
No more love
In the blues of the Varuna.

In this city
No love will wake up in luster,
Nobody else will ever find it
Anywhere in the muster.

Torments in mind and spirit,
Yet our lives flow and inherit.

ভুলে যাই সবই

ভুলে যাই সবই –
মাথার ভিতরে ঝিকিমিকি জোনাকি,
তোমারে ফিরে পাবো নাকি
বলিতে পারেনা বিস্তীর্ণ বিস্মরণ।

বেদনায় চৌচির সবই –
দরজার ওপাশে হাসে মৃত্যদূত,
এপাশে হৃদয়ে থামে রক্তস্রোত;
হায়রে জীবন, পরাজিত জীবন।

এই শহরের সব ভালোবাসা

এই শহরের সব ভালোবাসা
মরে গেছে ভাইরাসে,
তুমি আর তারে
পাবে না হৃদয়ের ক্যানভাসে।
ভালোবাসা নেই আর
গোলাপের সুরভিত সৌরভে,
ভালোবাসা নেই আর
রমণীর মুখরিত গৌরবে।
ভালোবাসা নেই আর
যমুনার কালো জলে,
ভালোবাসা নেই আর
শ্রাবণের নবধারা ঢলে।
এই শহরে কোন ভালোবাসা
আর জাগিবেনা উদ্ভাসে,
কেউ আর তারে
পাবেনা কারো উল্লাসে।
মন ও মননে অসহ্য পীড়ন,
তবুও চলছে সাধের জীবন।

পদ্মার বুকে আমি পদ্মা সেতু

পদ্মার বুকে আমি পদ্মা সেতু
ডুবায়েছি দুষ্ট জনের দুষ্ট হেতু;
বাঁধিয়াছি দুই পাড় এক সূত্রে
সতেরো কোটি বাঙালীর স্বপ্নীল নেত্রে।

করিয়াছি জয় অনন্ত উন্মত্ত জলরাশি
নাশিয়া সকল অসুর কনক্রিট পিলারে;
সুখে-দুখে বাঁচিয়া থাকিব শত বছর
অজস্র জনেরে বাঁচাইয়া দুই কিনারে।

তোমাদের প্রজ্ঞা গ্রন্থিত আমার শরীরে
চলো রাখি দেশটাকেই বুকের গভীরে;
তোমাদের প্রত্যয় আমার রন্ধ্রে রন্ধ্রে,
চলো পথ চলি মৃত্যঞ্জয়ী জীবনমন্ত্রে।

Lotus-Leaf-Inspired Biomimetic Coatings: Different Types, Key Properties, and Applications in Infrastructures

Abstract:
A universal infrastructural issue is wetting of surfaces; millions of dollars are invested annually for rehabilitation and maintenance of infrastructures including roadways and buildings to fix the damages caused by moisture and frost. The biomimicry of the lotus leaf can provide superhydrophobic surfaces that can repel water droplets, thus reducing the penetration of moisture, which is linked with many deterioration mechanisms in infrastructures, such as steel corrosion, sulfate attack, alkali-aggregate reactions, and freezing and thawing. In cold-region countries, the extent of frost damage due to freezing of moisture in many components of infrastructures will be decreased significantly if water penetration can be minimized. Consequently, it will greatly reduce the maintenance and rehabilitation costs of infrastructures. The present study was conducted to explore any attempted biomimicry of the lotus leaf to produce biomimetic coatings. It focuses on anti-wetting characteristics (e.g., superhydrophobicity, sliding angle, contact angle), self-cleaning capability, durability, and some special properties (e.g., light absorbance and transmission, anti-icing capacity, anti-fouling ability) of lotus-leaf-inspired biomimetic coatings. This study also highlights the potential applications of such coatings, particularly in infrastructures. The most abundant research across coating materials showed superhydrophobicity as being well-tested while self-cleaning capacity and durability remain among the properties that require further research with existing promise. In addition, the special properties of many coating materials should be validated before practical applications.

লাল-সবুজ টিপ

কপালে লাল-সবুজ টিপ
লাগছে বেশ!
যেন সারা বিশ্বের বুকে
একটি বাংলাদেশ।
ঝড়ো হাওয়ায় যদি কখনো
নিভে যায় দীপ,
অশনির আলোয় অন্ধকারে
দেখি যেন ঐ টিপ।
হে নারী, উন্নত শিরে
পরো লাল-সবুজ টিপ,
আসুক যতই ফিরে ফিরে
ভিন্ন সময় ভীষণ বিপ্রতীপ।

Probable Causes of Blood Clotting Driven by SARS-CoV-2

Coronavirus Disease 2019 (COVID-19) has transmitted almost all over the world. COVID-19 is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which transfers from an infected person to a susceptible person via direct contact (e.g., hand-shaking, hugging) or indirect contact through touching materials or objects that are contaminated by an infected person (e.g., doorknob, handrail, paper tissue). It can also spread via airborne route (i.e. through aerosols created by expiratory activities). After entering the respiratory tract of human body, SARS-CoV-2 bioparticles may cause the most common symptoms of fever, cough, and fatigue. They may also cause sore throat, headache, chill, runny nose, loss of taste or smell, skin rash, muscle pain, nausea and vomiting, loss of appetite, diarrhea, dizziness, abdominal pain, and discoloration of fingers or toes. The severe symptoms of COVID-19 are shortness of breath or difficulty in breathing, chest pain, and loss of speech or movement. Recently, blood clotting has emerged as a new risk of COVID-19. Indeed, skin rash and discoloration of fingers or toes are the visible signs of blood clotting. The reduction of oxygen level in blood is another indication of blood clotting, as the oxygen supply to the tissues and organs of human body will be greatly affected if blood clots occur. The following are the probable causes of blood clotting.

1. SARS-CoV-2 particles can increase the viscosity of blood because of their own physical characteristics. The outer surface of SARS-CoV-2 having protein spikes may cause friction with other ingredients of blood (e.g., red cells, white cells, and platelets) and among themselves. They can also cause friction on the surface of the innermost layer (tunica intima) of blood vessels. It means the blood flow in the blood vessels will be hindered due to the increased resistance against flow. Such impaired blood flow may contribute to cause blood clotting.

2. SARS-CoV-2 particles may increase the viscosity of blood by increasing the concentration of the bioparticles in blood. The viscosity of whole blood is directly related to the viscosity of its plasma (the higher the viscosity of plasma, the greater will be the viscosity of whole blood) and the concentration (volume fraction) of the bioparticles present in blood (the larger the concentration of the bioparticles, the greater will be the viscosity of whole blood). This means the effective viscosity of whole blood will increase with the increasing volume fraction of the bioparticles existing in blood. It implies that the whole blood shall be thicker when the increased load of virus particles increases the volume concentration of the bioparticles in blood. The extremely increased viscosity could lead to blood clotting in human body.

3. SARS-CoV-2 particles could interlock with each other because of their characteristic outer layer having protein spikes, leading to formation of virus cluster. This physical process may also involve other blood particles (e.g., blood cells). In addition, the stickiness of the envelope of SARS-CoV-2 due to its spike protein (S-protein) and envelope protein (E-protein) could help forming the clusters of virus particles and blood cells. It implies that SARS-CoV-2 may collectively form obstacles across the blood flow direction, thus contributing to blood clotting.

4. SARS-CoV-2 particles may attach to the inner lining (tunica intima) of blood vessels, taking the benefit of their sticky outer layer, thus narrowing the vessel space along the direction of the blood flow (i.e., the cross-sectional area of blood vessels across the blood flow direction decreases). It is also possible that SARS-CoV-2 particles assemble in several layers with the foremost layer attaching to the tunica intima of blood vessels. Such array of virus particles will also decrease the cross-sectional area of the blood vessel across the blood flow direction. Consequently, the blood flow will be significantly obstructed. Furthermore, the endothelial cells of tunica intima may not help regulate the pressure for blood flow when they are lined with SARS-CoV-2 particles. The production of enzymes (e.g., nitric oxide) that help inhibit blood clotting may also be impeded when the endothelial cells are attacked by SARS-CoV-2 particles. These probable consequences eventually may cause blood clotting in extreme condition.

5. The physical structure of tunica intima reveals that SARS-CoV-2 particles could easily be attached to the endothelial cell-to-cell links. These links are very thin compared to the other parts of tunica intima. Hence, the inner lining can easily be ruptured by SARS-CoV-2 particles at those thin links and the underlying internal elastic membrane can be exposed. This damage may trigger blood clotting inside the blood vessels. The breaching of tunica intima shall result in rushing of additional platelets and clotting factors (e.g., prothrombin, fibrinogen) to the damage sites and they will start the process for the formation of blood clots.

6. SARS-CoV-2-induced cytokine storm may be another reason of blood clotting in the blood vessels. Coronaviruses can reach different locations of human body including the blood vessels although they first penetrate the lungs. When the endothelial cells in tunica intima are injured by SARS-CoV-2, they send “SOS” to the immune cells, which rush to the damage sites. The immune cells crowd on the damage sites. The activated immune cells secrete small proteins called cytokines, which prevent the pathogens (e.g., bacteria, viruses) from spreading in the body, contributing to blood coagulation (thickening) with increased viscosity. However, excessive cytokines may lead to uncontrollable blood coagulation. In such condition, anti-coagulants (thinner) present in the whole blood are not quite enough to inhibit blood clotting.

7. SARS-CoV-2 particles would decrease the velocity of whole blood being in the blood vessel. This is due to the additional mass of viruses or owing to the thickening of blood in the presence of virus particles. Since blood is a non-Newtonian flow, its viscosity increases at a lower velocity. Also, the low flow state of blood enhances the molecular interactions of blood cells among themselves and with plasma proteins. Consequently, blood cells (particularly red cells) can agglomerate to form clusters of cells, and thus further increase the viscosity of blood. At a very high viscosity caused by high degree of molecular interactions, blood may stop flowing if the driving pressure remains below the yield stress that initiate flow. Moreover, platelets can get closer at a higher viscosity and the cluster of platelets, acting along with plasma proteins, can entrap red cells to form blood clotting.

বঙ্গবন্ধু

উৎসর্গঃ বঙ্গবন্ধু

বাংলার পথে, বাংলার জলে চিরঞ্জীব
বিশ্ববন্ধু, বঙ্গবন্ধু শেখ মুজিব।…
বাংলার মাঠে, বাংলার ঘাসে সতেজ-সজীব
বিশ্ববন্ধু, বঙ্গবন্ধু শেখ মুজিব।…
বাংলার গানে, বাংলার প্রাণে অতন্দ্র উদ্গ্রীব
বিশ্ববন্ধু, বঙ্গবন্ধু শেখ মুজিব।…
বাংলার দুঃখে, বাংলার শোকে মির্জা গালিব
বিশ্ববন্ধু, বঙ্গবন্ধু শেখ মুজিব।…

Net-Zero Energy Homes

|Obstacles to Developing Net-Zero Energy (NZE) Homes in Greater Toronto Area|

Ghazal Makvandia and Md. Safiuddin

Abstract: Efforts have been put in place to minimize the effects of construction activities and occupancy, but the problem of greenhouse gas (GHG) emissions continues to have detrimental effects on the environment. As an effort to reduce GHG emissions, particularly carbon emissions, countable commercial, industrial, institutional, and residential net-zero energy (NZE) buildings were built around the globe during the past few years, and they are still operating. But there exist many challenges and barriers for the construction of NZE buildings. This study identifies the obstacles to developing NZE buildings, with a focus on single-family homes, in the Greater Toronto Area (GTA). The study sought to identify the technical, organizational, and social challenges of constructing NZE buildings, realize the importance of the public awareness in making NZE homes, and provide recommendations on how to raise public knowledge. A qualitative approach was employed to collect the primary data through survey and interviews. The secondary data obtained from the literature review were also used to realize the benefits, challenges, and current situation of NZE buildings. Research results indicate that the construction of NZE buildings is faced with a myriad of challenges, including technical issues, the lack of govern-mental and institutional supports, and the lack of standardized measures. The public awareness of NZE homes has been found to be very low, thus limiting the uptake and adoption of the new technologies used in this type of homes. The present study also recommends that the government and the academic institutions should strive to support the NZE building technology through curriculum changes, technological uptake, and financial incentives to buyers and developers. The implementation of these recommendations may enhance the success and popularity of NZE homes in the GTA.

N95 Respirator Masks: Are they Sufficient for Protection against COVID-19?

COVID-19 (Coronavirus Disease 2019), evolving from China in December 2019, has spread almost all over the world. This disease is caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), which transfers from one person to another through respiratory droplets and aerosols created by expiratory activities. The transmission of coronaviruses occurs when the respiratory droplets and aerosols emitted from an infected person reach the nose, mouth, or eyes of another person [1,2]. Coronaviruses can transfer directly through human-to-human contact (e.g., handshaking, hugging), indirectly through touching materials or objects that carry infection (e.g., doorknob, handrail, paper tissue), and via airborne route [3]. The transmission of coronaviruses can be prevented using highly efficient face masks. N95 respirator masks are being used as “high-efficiency masks” in the current pandemic situation. But are they sufficient for protection against coronaviruses?

As per the guideline of WHO, health-care professionals must wear masks when caring for patients with airborne infections, or when executing bronchoscopies or similar tests for their own protection; in such cases, “high-efficiency masks” are recommended [4]. In battling against SARS-CoV-2, health-care staff are using N95 respirator masks. But N95 respirator masks may not certainly provide adequate protection against coronaviruses, which are significantly smaller than 300nm (0.3µm) inert particles used in the acceptance test of this type of masks [5]. The diametrical size of viruses varies in the range of 20–300 nm (0.02–0.3 µm). SARS-CoV-1 ranges from 75 nm (0.075 µm) to 160 nm (0.160 µm) in diameter [6] whereas SARS-CoV-2 varies from 65 nm (0.065 µm) to 125 nm (0.125 µm) [7]. Thus, the penetration of coronaviruses through N95 respirator masks could be more than 5% due to their very small size. The research results of Bałazy et al. [5] showed that N95 respirator masks will be adequate against the particles ≥ 300 nm in diameter; but they may not give proper protection with 95% threshold value for the nano-size virus particles; in their study, the penetration of small virus particles less than 80 nm was 2.25–3.25% at a lower inhalation rate of 30 L/min whereas it was 4.25–5.75% at a higher inhalation rate of 85 L/min. Furthermore, the wearer may not get the desired level of protection unless the respirator is fitted well with the face without any leakage [8]. All these mean that the 95% protection level of N95 masks is not guaranteed for the health-care professionals giving treatment to COVID-19 patients.

In fine, N95 respirator masks are not 95% effective in preventing virus particles during inhalation. The nano-size coronavirus could penetrate N95 respirator masks by more than 5%. A 5% penetration may not be very harmful in the case of inert particles. Conversely, a very little penetration of coronaviruses would be enough to cause substantial damage. This is because sometimes a single virus particle can cause infection [6]. Therefore, relying solely on N95 respirator masks strategically will not be sufficient to prevent coronaviruses from entering the respiratory tract. A better option could be to use it as an element in the practice of multi-level protection; for example, a face shield on top of a google for eye protection and an N95 respirator mask alone or covered by a surgical mask for nose and mouth protection. Alternatively, full-facepiece air-purifying respirators (APRs) and powered air-purifying respirators (PAPRs) can be used by the health-care personnel for protection against COVID-19 [9,10]. APRs and PAPRs simultaneously cover eyes, nose, and mouth. They are reusable and can be used more than once following the guidelines for cleaning, sanitizing, and/or disinfecting [11,12]. Both APRs and PAPRs are used with disposable filters and most common filters are N95 and P100. But N95 filters will not give more than 95% protection as discussed earlier. High-level respiratory protection is expected to achieve by P100 filters. A P100 filter is effective against all particulate aerosols and 99.97% efficient against 0.3µm particles [13]. It means that the penetration of 0.3µm particles through a P100 filter should not be more than 0.03%. Therefore, APRs and PAPRs with P100 filters would likely give better protection than N95 respirator masks against COVID-19. The assigned protection factor is 50 and 1000 for full-facepiece APRs and PAPRs, respectively, whereas it is only 10 for N95 respirator masks [13-15].

List of References:

[1] Mount Sinai Hospital. FAQ: Methods of Disease Transmission. Department of Microbiology, Mount Sinai Hospital: Toronto, Ontario, Canada. Retrieved on March 31, 2020. Available online: https://eportal.mountsinai.ca/Microbiology/faq/transmission.shtml.
[2] World Health Organization (WHO). Pass the Message: Five Steps to Kicking out Coronavirus. WHO: Geneva, Switzerland; March 23, 2020. Retrieved on March 24, 2020. Available online: https://www.who.int/news-room/detail/23-03-2020-pass-the-message-five-steps-to-kicking-out-coronavirus.
[3] Asadi, S.; Bouvier, N.; Wexler, A.S.; Ristenpart, W.D. The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles? Aerosol Science and Technology 2020, 54(6), 635-638.
[4] World Health Organization (WHO). Prevention of Hospital-Acquired Infections: A Practical Guide; Second Edition, WHO/CDS/CSR/EPH/2002.12; Ducel, G., Fabry, J., Nicolle, L., Eds.; WHO: Geneva, Switzerland, 2002. Retrieved on March 26, 2020. Available online: https://www.who.int/csr/resources/publications/whocdscsreph200212.pdf.
[5] Bałazy, N.; Toivola, M.; Adhikari, A.; Sivasubramani, S.K.; Reponen, T.; Grinshpun, S.A. Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? American Journal of Infection Control 2006, 34(2), 51-57.
[6] Morawska, L. Droplet fate in indoor environments, or can we prevent the spread of infection. Indoor Air 2006, 16(5), 335-347.
[7] Shereen, M.A.; Khan, S.; Kazmi, A.; Bashir, N.; Siddique, R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research 2020, 24, 91-98.
[8] Coffey, C.C; Lawrence, R.B.; Campbell, D.L.; Zhuang, Z.; Calvert, C.A.; Jensen, P.A. Fitting characteristics of eighteen N95 filtering-facepiece respirators. Journal of Occupational and Environmental Hygiene 2004, 1(4), 262-271.
[9] FDA (Food and Drug Administration). N95 Respirators and Surgical Masks (Face Masks). U.S. Food and Drug Administration: Maryland, USA. Retrieved on March 28, 2020. Available online: https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-and-surgical-masks-face-masks#s2.
[10] CDC (Centre for Disease Control and Prevention). Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings. CDC: Atlanta, Georgia, USA. Retrieved on May 13, 2020. Available online: https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Finfection-control%2Fcontrol-recommendations.html.
[11] 3M (Minnesota Mining and Manufacturing) Canada. How to Inspect, Clean and Store 3M™ Reusable Respirators. 3M: London, Canada: Retrieved on May 14, 2020. Available online: file:///F:/COVID19%20Paper%201/Literature/How-to-Inspect-Clean-and-Store-3M-Reusable-Respirators.pdf
[12] 3M (Minnesota Mining and Manufacturing) United States. Guidelines for Cleaning and Disinfecting the 3M™ Powered Air Purifying Respirator (PAPR) TR-300 Assembly. 3M: Minneapolis USA; June 17, 2016. Retrieved on May 14, 2020. Available online: https://www.3m.com/3M/en_US/worker-health-safety-us/all-stories/full-story-detail/?storyid=e706502a-0c64-4783-9f00-6248893619a1.
[13] The National Academies of Science, Engineering and Medicine. Reusable Elastomeric Respirators in Health Care. Clever, L.H., Rogers, B.M.E., Yost, O.C., Liverman, C.T., Eds.; The National Academies Press: Washington D.C., USA, 2019.
[14] Rengasamy, S.; Walbert, G.; Newcomb, W.; Coffey, C.; Wassell, J.T.; Szalajda. J. Protection factor for N95 filtering facepiece respirators exposed to laboratory aerosols containing different concentrations of nanoparticles. The Annals of Occupational Hygiene 2015, 59(3), 373–381.
[15] Vo, E.; Zhuang, Z.; Horvatin, M.; 2, Liu, Y.; He, X.; Rengasamy, S. Respirator performance against nanoparticles under simulated workplace activities. The Annals of Occupational Hygiene 2015, 59(8), 1012–1021.

Md. Safiuddin
Professor
George Brown College, Casa Loma Campus
146 Kendal Avenue, C Building, Room C303
Toronto, Ontario, Canada M5T 2T9
Adjunct Professor, Department of Civil Engineering
Ryerson University, Toronto, Ontario, Canada M5B 2K3
College Website: https://www.georgebrown.ca/facultybios/Md.-Safiuddin.aspx
Google Scholar: https://scholar.google.ca/citations?user=WboBlwQAAAAJ&hl=en
Research Gate: https://www.researchgate.net/profile/Md_Safiuddin